YETZONE S 1.5 INJECTIONCEFTRIAXONE 1gm. IP + SULBACTAM 500mg. IP

Yetzone S 1.5 Injection combines ceftriaxone and sulbactam for the treatment of susceptible bacterial infections. Main uses: lower respiratory tract infections caused by susceptible bacteria; acute bacterial otitis media (middle ear infection) caused by susceptible bacteria; skin and skin structure infections caused by susceptible bacteria; intra-abdominal infections caused by susceptible bacteria; gynaecological infections caused by susceptible bacteria.

Common side effects of Yetzone S 1.5 Injection include pain, redness, swelling or hardness at the injection site; phlebitis or warmth along the vein after intravenous use; rash; diarrhoea or loose stools; nausea or vomiting; raised liver enzyme levels in blood tests. Get medical help at once if you notice severe allergic reactions, including anaphylaxis; severe skin reactions; pseudomembranous colitis (severe diarrhoea during or after antibiotic use).

Yetzone S 1.5 Injection contains Ceftriaxone 1 g + Sulbactam 500 mg. Yetzone S 1.5 Injection is given by a doctor or nurse, who decides the dose and how often it is given.

The MRP of Yetzone S 1.5 Injection is ₹190 for a pack of 1. For chemists and distributors, the PTR is ₹144.76 and the PTS is ₹130.29.

Yetzone S 1.5 Injection contains Ceftriaxone 1 g + Sulbactam 500 mg. It comes in a pack of 1.

The two ingredients work as a pair. Ceftriaxone is a cephalosporin antibiotic that interferes with the cell wall of bacteria so they are unable to grow. Sulbactam is a beta-lactamase inhibitor. Certain bacteria produce enzymes that break down antibiotics, and Sulbactam stops those enzymes from acting, which supports the activity of Ceftriaxone against those organisms.

Must not be used by anyone with a known allergy to ceftriaxone, sulbactam or any other cephalosporin. Must not be used by anyone with a history of a serious hypersensitivity reaction (such as anaphylaxis or Stevens-Johnson syndrome) to other beta-lactam antibiotics. Must not be used in premature newborn babies up to a post-menstrual age of 41 weeks. Must not be used in newborn babies with high bilirubin (jaundice). Must not be used in newborn babies who need calcium-containing intravenous fluids, and check with a doctor first if you have had an allergy to penicillins, kidney or liver problems, a history of antibiotic-related colitis, or if you are pregnant or breastfeeding.

Yetzone S 1.5 Injection is a brand of Vibcare Pharma, sold through its Auspin division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.